When: Confirmed close above $345.37 on >3M shares with MACD re-expansion

Then: Upgrade to Overweight; structural breakout re-established

SELL

• FDX recommendation is SELL/REDUCE as a staged, conditional trim rather than high-conviction short
• Current price at $334.05 with 50-SMA at $319.51 and 200-SMA at $285.08
• Forward P/E ~16x, dividend yield 1.5%, price-to-book ~2.53x
• Fiscal 2026 revenue +7.7%, operating income +9.8%, free cash flow $5.116 billion
• Net leverage 1.05-1.11x EBITDA, current ratio 1.475, cash $13.311 billion
• Latest quarter: normalized EBITDA +14.5%, normalized income +14.2%, sequential EBITDA +22%, net income +51.2%
• Unusual charges rose from $426M (FY2023) to $1.160B (FY2026)
• Latest quarter showed 12.5% revenue growth, 124bps EBITDA margin compression, 4.1% EPS decline, $538M unusual items, $515M restructuring charges
• $345 stop is only half of $8.01 ATR; latest daily range was $10.07, creating gap risk
• RSI 60.99 shows positive momentum; stock below $341.34 resistance zone
• Recommend limit trims around $339-$341 after failed breakout rather than forced sale
• $327.69 10-EMA is early warning level; close below $319.51 on expanding volume triggers reduction
• A close above $345.37 on strong volume invalidates bearish tactical setup
• Proceeds should remain in cash or pre-approved lower-risk reserve rather than unnamed momentum names

→ vs aggressive: The 2-to-1 payoff calculation is applied to the wrong trade; a short entered at $341 risks $4 to $345 stop vs $21.50 potential downside, which is favorable only if $319 is reached without touching $345 first

→ vs aggressive: The $345 stop is only half of the $8.01 ATR and $345.37 is the 52-week high; normal volatility or FOMC-related gap could easily hit the stop before confirmed bearish breakdown

→ vs aggressive: The $285 target is nearly 15% away and assumes the 200-SMA is a guaranteed destination; it is a possible scenario but not a reliable tactical target

→ vs aggressive: Execution ambiguity: proposal must clarify whether it is a trim of existing position or naked short; the two have materially different risk profiles including squeeze, gap, and event risk

→ vs aggressive: The DCF 34% upside claim has low-confidence sentiment data; the aggressive claim that FDX will inevitably trade at 12x earnings is unsupported and is a possible scenario, not a forecast

→ vs aggressive: Fiscal 2026 fundamentals show 7.7% revenue growth, 9.8% operating income growth, and $5.116B FCF; do not eliminate restructuring risk but argue against treating 4.1% EPS decline as proof of irreversible collapse

→ vs aggressive: Amazon threats and industry layoffs are reasons to demand lower valuation and tighter position limits, not reasons to assume last-mile economics are already broken; no direct FDX volume loss, yield decline, or margin impact demonstrated

→ vs neutral: The bullish moving-average stack, RSI 60.99, expanding MACD, and rising VWMA show FDX can still move higher; an uncovered short at $341 fights positive momentum and constructive institutional narrative

→ vs neutral: The recommendation to wait for 8%-12% pullback is not sufficiently conservative; lower price does not repair margin pressure, recurring restructuring costs, or questionable FCF improvement

→ vs neutral: A break below 50-SMA should trigger review, not automatically become a buying opportunity; a close above $341.34 should trigger reassessment, not automatically justify full BUY

TRIM (not short) FDX exposure in the $338-$341 zone with resistance-confirmed exits; keep powder dry in cash; invalidate bearish thesis if price breaks above $345 on expanding volume; do not execute before September FOMC

• Current price at $334.05, near 52-week high of $345, just below upper Bollinger band at $341
• Aggressive's $4 stop at $345 from $341 entry is below FDX's daily ATR of $8.01 and yesterday's $10.07 single-day range—statistically likely to get clipped by routine volatility
• Restructuring charges grew from $426M to $1.16B over three years, but 72% FCF jump to $5.1B and 14.5% normalized EBITDA growth suggest operating improvement
• FOMC September 16th hawkish surprise probability is 34% (one-in-three) based on prediction markets with unavailable FRED data—low-quality information
• Recommend trim (not short): scale out one-third at ~$339 resistance, another third on confirmed rejection, hold final third with 50-SMA at $319.51 as invalidation
• Any new short exposure requires minimum 1.5x ATR stop (~$12 wide from $341 entry), not the $4 stop the trader proposed
• 86% trailing twelve-month return makes technical setup more vulnerable near resistance
• Do not rotate into unnamed momentum names—park proceeds in cash or defined lower-volatility reserve until clearer alternatives identified

→ vs aggressive: 2-to-1 reward-to-risk calculation is misleading because entry is $341, not current $334.05; stop is below ATR and likely to be clipped by routine $10+ single-day moves before bearish thesis plays out

→ vs aggressive: Rotation thesis is weakest—identifies no specific names, shows no relative valuation or correlation work; rolling into unspecified basket is hope, not portfolio construction

→ vs aggressive: Macro argument overweighted to 34% tail scenario while treating 64% hold probability as irrelevant; prediction-market probabilities flagged as low-quality, unavailable FRED data

→ vs conservative: 'Conditional underweight with staged execution' is too cautious—if bear case is credible, waiting for 8-12% pullback before trimming means selling lower if correct and holding through pain if wrong; logical contradiction

→ vs conservative: Nested conditional triggers (close above $345 cancels, below $319 triggers, margins must deteriorate, FCF must weaken, guidance must soften) are so layered they essentially never fire; will hold through most plausible scenarios

→ vs conservative: Technical analysis inconsistent—criticizes aggressive's $345 stop for being too tight relative to ATR but doesn't acknowledge own upside resistance setup is now more vulnerable given 86% TTM return and proximity to 52-week high